Is Medtronic plc (MDT) Undervalued?
The traditional Graham Number cannot be calculated for Medtronic plc (MDT) due to missing data. Consider using DCF or other valuation methods for a complete picture.
Analysis updated March 6, 2026
MDT Key Valuation Metrics
| Metric | Value | Signal |
|---|---|---|
| Current Price | $91.11 | — |
| Graham Number | N/A | — |
| P/E Ratio | N/A | Unprofitable |
| P/B Ratio | N/A | — |
| DCF Fair Value | N/A | — |
| Dividend Yield | 3.11% | ▲ High |
| 52-Week Range | $79.55 – $106.33 | Mid-range |
| Market Cap | N/A | Micro Cap |
| Sector | Healthcare | — |
How We Calculated MDT's Graham Number
The Graham Number, developed by Benjamin Graham (the father of value investing), estimates a stock's maximum fair price based on its earnings and book value.
Graham Number = √(22.5 × EPS × BVPS)
For Medtronic plc (MDT):
- Earnings Per Share (EPS): N/A
- Book Value Per Share (BVPS): N/A
MDT Dividend Profile
Medtronic plc currently pays a quarterly dividend of $0.71 per share, yielding 3.11% at the current price.
| Annual Dividend | $2.83 |
| Dividend Yield | 3.11% |
| Payout Ratio | N/A |
| Consecutive Years Paid | 0+ years |
| 5-Year Dividend Growth | N/A |
| Payment Frequency | Quarterly |
👑 Medtronic plc is a Dividend Aristocrat — it has increased its dividend for 25+ consecutive years.
MDT Value Score: 1/10
Our proprietary value score rates Medtronic plc a 1 out of 10, placing it in the “Overvalued / Caution” category for value investors.
Score Components
Graham Number not available
P/E not available
P/B not available
DCF value not available
Solid 3.1% yield
Weak balance sheet metrics
Score methodology: How We Score Stocks
Stocks Similar to MDT
These Healthcare stocks have similar valuation profiles to Medtronic plc:
Frequently Asked Questions About MDT
Is MDT undervalued right now?
Based on Graham Number analysis, MDT does not appear significantly undervalued as of March 6, 2026. The Graham Number of $N/A compared to the current price of $91.11 indicates a N/A% difference.
What is Medtronic plc's intrinsic value?
Using our DCF model, Medtronic plc's estimated intrinsic value is $N/A per share. The Graham Number suggests a fair value of $N/A.
What is the Graham Number for MDT?
The Graham Number for MDT is $N/A, calculated using EPS of $N/A and Book Value Per Share of $N/A. The formula is sqrt(22.5 x EPS x BVPS).
Does MDT pay a dividend?
Yes, MDT pays dividends with a yield of 3.11%. The annual dividend is $2.83 per share. It has paid dividends for 0+ consecutive years.
Is MDT a good buy right now?
Our value score rates MDT a 1/10. The stock is in the "Overvalued / Caution" category. However, this is analysis — not financial advice. Consider your own risk tolerance, portfolio allocation, and investment timeline before making any decisions.
Start Analyzing MDT Today
Ready to invest in Medtronic plc? Open a free brokerage account and start trading MDT with $0 commissions.
We may earn a commission when you open an account through our links. This does not affect our analysis or ratings.
Learn More About Value Investing
Tools
- Graham Number Calculator — Calculate the Graham Number for any stock
- DCF Calculator — Run your own discounted cash flow analysis
- Stock Screener — Filter stocks by value metrics
Related Articles
About Medtronic plc
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repa...
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial advice, a recommendation, or a solicitation to buy or sell any security. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions. Data sourced from Financial Modeling Prep API and may be delayed. Last updated: March 6, 2026.